Search research articles
Contact Us
Filters
Showing results (451-460 of 512) with videos related to
Page
of 52
Sort By:
Oncoimmunology
|
April 7, 2025
Surrogate markers of intestinal dysfunction associated with survival in advanced cancers
Roxanne Birebent, Damien Drubay, Carolina Alves Costa Silva, et al.
The Lancet. Oncology
|
June 12, 2021
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
Justin F Gainor, Giuseppe Curigliano, Dong-Wan Kim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 5, 2025
EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer
Jessica Menis, Laurent Greiller, Pierre Demontrond, et al.
Cancer Discovery
|
September 13, 2024
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations
Jessica J Lin, Joshua C Horan, Anupong Tangpeerachaikul, et al.
European Urology Oncology
|
March 4, 2024
Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer
Ludovic Bigot, Jonathan Sabio, Loic Poiraudeau, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 3, 2019
Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
Paul M Putora, Markus Glatzer, José Belderbos, et al.
NPJ Precision Oncology
|
December 18, 2021
Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancer
Diana Schaufler, David F Ast, Hannah L Tumbrink, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 25, 2019
Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
Paul Martin Putora, Markus Glatzer, Dirk De Ruysscher, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 8, 2019
Erratum to "Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts" [Radiother. Oncol. 135 (2019) 74-77]
Paul Martin Putora, Markus Glatzer, Dirk De Ruysscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2023
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy
Helena A Yu, Yasushi Goto, Hidetoshi Hayashi, et al.
Page
of 52
Search research articles
Search
Showing results (451-460 of 512) with videos related to
Sort By:
Page
of 52
Oncoimmunology
|
April 7, 2025
Surrogate markers of intestinal dysfunction associated with survival in advanced cancers
Roxanne Birebent, Damien Drubay, Carolina Alves Costa Silva, et al.
The Lancet. Oncology
|
June 12, 2021
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
Justin F Gainor, Giuseppe Curigliano, Dong-Wan Kim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 5, 2025
EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer
Jessica Menis, Laurent Greiller, Pierre Demontrond, et al.
Cancer Discovery
|
September 13, 2024
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations
Jessica J Lin, Joshua C Horan, Anupong Tangpeerachaikul, et al.
European Urology Oncology
|
March 4, 2024
Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer
Ludovic Bigot, Jonathan Sabio, Loic Poiraudeau, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 3, 2019
Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
Paul M Putora, Markus Glatzer, José Belderbos, et al.
NPJ Precision Oncology
|
December 18, 2021
Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancer
Diana Schaufler, David F Ast, Hannah L Tumbrink, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 25, 2019
Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
Paul Martin Putora, Markus Glatzer, Dirk De Ruysscher, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 8, 2019
Erratum to "Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts" [Radiother. Oncol. 135 (2019) 74-77]
Paul Martin Putora, Markus Glatzer, Dirk De Ruysscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2023
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy
Helena A Yu, Yasushi Goto, Hidetoshi Hayashi, et al.
Page
of 52